- Home
- MIND vs MRSN Comparison
MIND vs MRSN Comparison
Compare MIND & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIND
- MRSN
- Stock Information
- Founded
- MIND 1987
- MRSN 2001
- Country
- MIND United States
- MRSN United States
- Employees
- MIND N/A
- MRSN N/A
- Industry
- MIND Industrial Machinery/Components
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- MIND Industrials
- MRSN Health Care
- Exchange
- MIND Nasdaq
- MRSN Nasdaq
- Market Cap
- MIND 49.6M
- MRSN 40.7M
- IPO Year
- MIND 1994
- MRSN 2017
- Fundamental
- Price
- MIND $7.86
- MRSN $0.29
- Analyst Decision
- MIND
- MRSN Strong Buy
- Analyst Count
- MIND 0
- MRSN 5
- Target Price
- MIND N/A
- MRSN $5.75
- AVG Volume (30 Days)
- MIND 519.0K
- MRSN 2.8M
- Earning Date
- MIND 06-10-2025
- MRSN 08-12-2025
- Dividend Yield
- MIND N/A
- MRSN N/A
- EPS Growth
- MIND N/A
- MRSN N/A
- EPS
- MIND 2.91
- MRSN N/A
- Revenue
- MIND $45,087,000.00
- MRSN $34,006,000.00
- Revenue This Year
- MIND $7.27
- MRSN N/A
- Revenue Next Year
- MIND N/A
- MRSN $1.30
- P/E Ratio
- MIND $2.79
- MRSN N/A
- Revenue Growth
- MIND 26.68
- MRSN N/A
- 52 Week Low
- MIND $3.05
- MRSN $0.26
- 52 Week High
- MIND $11.10
- MRSN $2.83
- Technical
- Relative Strength Index (RSI)
- MIND 59.57
- MRSN 38.23
- Support Level
- MIND $8.34
- MRSN $0.27
- Resistance Level
- MIND $8.85
- MRSN $0.36
- Average True Range (ATR)
- MIND 0.65
- MRSN 0.03
- MACD
- MIND 0.10
- MRSN -0.01
- Stochastic Oscillator
- MIND 64.53
- MRSN 16.81
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.